CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-09 | Garner Thomas EVP, Chief Commercial Officer | Grant or award · Restricted Stock Units | +45,372 | 45,372 | ||
| 2024-11-19 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Sale | −10,329 | $16.81 | $174K | 62,105 |
| 2024-11-19 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Sale | −4,073 | $16.81 | $68K | 19,863 |
| 2024-11-19 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sale | −10,259 | $16.81 | $172K | 53,302 |
| 2024-11-17 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Option exercise | +9,913 | 62,521 | ||
| 2024-11-17 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Option exercise | +9,913 | 72,434 | ||
| 2024-11-17 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Option exercise · Restricted Stock Units | −9,913 | 9,913 | ||
| 2024-11-17 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | Option exercise · Restricted Stock Units | −9,913 | 9,913 | ||
| 2024-11-17 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise | +3,965 | 19,971 | ||
| 2024-11-17 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise | +3,965 | 23,936 | ||
| 2024-11-17 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | −3,965 | 3,966 | ||
| 2024-11-17 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | −3,965 | 3,966 | ||
| 2024-11-17 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise | +9,913 | 53,648 | ||
| 2024-11-17 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise | +9,913 | 63,561 | ||
| 2024-11-17 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −9,913 | 9,913 | ||
| 2024-11-17 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −9,913 | 9,913 | ||
| 2024-10-12 | Ndu Adora Director | Option exercise | +4,381 | 15,414 | ||
| 2024-10-12 | Ndu Adora Director | Option exercise · Restricted Stock Units | −4,381 | 0 | ||
| 2024-09-23 | Adams Catherine Owen Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +353,261 | 353,261 | ||
| 2024-08-19 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sale | −9,733 | $15.28 | $149K | 43,735 |
Page 10 of 63 · 1,260 trades